Wegovy in india Danish drugmaker Novo Nordisk has launched its weight loss drug Wegovy as a once-a-week injection in India on June 24.Wegovy is already under distribution and is expected to be in pharmacies by the end of the month, Novo Nordisk India Managing Director Vikrant Shrotriya said at a briefing.
A new chapter in obesity care now that global weight-loss drugs have entered the market.
Wegovy in India to compete with Lilly’s Mounjaro
A major face-off is expected in India’s growing anti-obesity treatment market, as Danish pharma giant Novo Nordisk rolled out its blockbuster weight-loss drug Wegovy on Tuesday, just a month after rival Eli Lilly launched Mounjaro.
Sales of Lilly’s weight-loss drug Mounjaro jumped 60% between April and May, industry experts said.
Analysts said Wegovy, a once-a-week injection, had been priced competitively to Mounjaro in India, and that is likely to encourage wider adoption of those drugs.
Global demand for both Mounjaro and Wegovy has skyrocketed in recent years with supply limited, leading to shortages in countries such as the U.S.
Novo said in a separate statement to Reuters that it is not anticipating any supply constraints in India.
Flexpen-like devices’
Shrotriya clarified that Wegovy will be launched in flexpen-like devices and can be self-administered, not in vials that will need the drug to be injected with a syringe.
“We are launching all five strengths in FlexTouch (a pen-like device),” . A dial allows the user to set the dose. “And then you have four needles inside the pack for self-administration,” he added. SOURCE- THE ECONIMIC TIMES NEWS
MUST READ-“Diet can Improve Gut health:- A structured discription“
